Sort
16,300 grants matching “fatty liver disease”
The Role of Kisspeptin in Metabolism Regulation
$499,877Mehboob A Hussain · University Of California-Irvine · R01 · FY2024 · DK
Exploring the Function of MHC-II/Lag3 Axis in Brain Metastasis to Develop Novel Therapeutic Strategies
$499,828Dihua Yu · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
The Saint Louis University Component of the NASH Clinical Research Network
$499,784Brent A Neuschwander-Tetri · Saint Louis University · U01 · FY2018 · DK
RAGE, DIAPH1 and IRF7 and Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Disease
$499,778Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2024 · HL
Evidence of Toxicant-associated Fatty Liver Disease in WTC Responders
$499,759Andrea D. Branch · Icahn School Of Medicine At Mount Sinai · U01 · FY2022 · OH
Jagged-Notch signaling in NASH/fibrosis
$499,751Utpal Pajvani · Columbia University Health Sciences · R01 · FY2021 · DK
Hepatic TGFbeta1 in Control of Type 2 Diabetes and NASH via FoxO1 Signaling
$499,701Shaodong Guo · Texas A&M Agrilife Research · R01 · FY2025 · DK
HIV HCV Coinfection Antiviral Therapy and Fibrosis
$499,538David L Thomas · Johns Hopkins University · R01 · FY2008 · DA
Hepatic Steatosis Quantification with Ultrasound
$499,499Shigao Chen · Mayo Clinic Rochester · R01 · FY2025 · DK
Glucocorticoid-regulated transcription networks in macrophage biology
$499,486Inez Rogatsky · Hospital For Special Surgery · R01 · FY2019 · DK
Glucocorticoid-regulated transcription networks in macrophage biology
$499,486Inez Rogatsky · Hospital For Special Surgery · R01 · FY2020 · DK
Adiponectin signaling and macrophage function
$499,391Lily Q. Dong · University Of Texas Hlth Science Center · R01 · FY2024 · DK
Identification of metabolic regulators of glycerolipid synthesis and storage
$499,389Kivanc Birsoy · Rockefeller University · R01 · FY2021 · DK
Evidence of Toxicant-associated Fatty Liver Disease in WTC Responders
$499,346Andrea D. Branch · Icahn School Of Medicine At Mount Sinai · U01 · FY2023 · OH
Mechanisms of NAT2 Regulation of Insulin Resistance and Mitochondrial Dysfunction
$499,314Joshua Wiley Knowles · Stanford University · R01 · FY2022 · DK
ABCA1, ApoAI and Reverse Cholesterol Transport
$499,301Jonathan D Smith · Cleveland Clinic Lerner Com-Cwru · P01 · FY2014 · HL
A Glucocorticoid Receptor-SETDB2 Co-Regulated Liver Metabolic Gene Program
$499,165Timothy F Osborne · Johns Hopkins University · R01 · FY2024 · DK
Transcriptional and metabolic regulation of Treg cell specification for the control of allergic airway disease
$499,162Kai Yang · Indiana University Indianapolis · R01 · FY2024 · AI
Insulin Signaling and Metabolic Regulation in Adipocytes
$499,159Michael P Czech · Univ Of Massachusetts Med Sch Worcester · R37 · FY2012 · DK
Pathogenesis of Dyslipidemia and Atherosclerosis in the Diabetic State
$499,125Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2014 · HL
Evidence of Toxicant-associated Fatty Liver Disease in WTC Responders
$499,043Andrea D. Branch · Icahn School Of Medicine At Mount Sinai · U01 · FY2021 · OH
Johns Hopkins University, Baltimore, MD Field Center
$498,846Mariana Lazo Elizondo · Beth Israel Deaconess Medical Center · U10 · FY2016 · AA
Tissue Mechanisms of Aging in the Genetic Model C. elegans
$498,790James R Priess · Fred Hutchinson Cancer Center · R01 · FY2025 · AG
A Safe and Tolerable Niacin Analog for Treatment of Nonalcoholic Steatohepatitis
$498,785Claude Benedict · Arisaph Pharmaceuticals, Inc. · R43 · FY2015 · DK
Genetic determinants of NAFLD severity and progression
$498,594Johanna K Distefano · Translational Genomics Research Inst · R01 · FY2015 · DK